Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-25-040180
Filing Date
2025-04-28
Accepted
2025-04-28 16:05:26
Documents
19
Period of Report
2025-06-11

Document Format Files

Seq Description Document Type Size
1 FORM-DEF 14A tm252430-2_def14a.htm   iXBRL DEF 14A 934075
4 GRAPHIC bc_capandnetincome-4c.jpg GRAPHIC 56147
5 GRAPHIC bc_capandtsr-4c.jpg GRAPHIC 49777
6 GRAPHIC px_25astriaproxy1pg1-bw.jpg GRAPHIC 287381
7 GRAPHIC px_25astriaproxy1pg2-bw.jpg GRAPHIC 363803
8 GRAPHIC sg_jillcmilne-bw.jpg GRAPHIC 5617
  Complete submission text file 0001104659-25-040180.txt   3659573

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA atxs-20241231.xsd EX-101.SCH 6117
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxs-20241231_lab.xml EX-101.LAB 20406
21 EXTRACTED XBRL INSTANCE DOCUMENT tm252430-2_def14a_htm.xml XML 182146
Mailing Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37467 | Film No.: 25880252
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)